昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06826 昊海生物科技

未开盘 04-09 16:08:11

22.260

-0.340

-1.50%

最高22.620	最低22.120	成交量13.14万
今开22.600	昨收22.600	日振幅2.21%
总市值51.20亿	流通市值8.00亿	总股本2.30亿
成交额294.37万	换手率0.37%	流通股本3,593万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"昊海生物科技","latestPrice":22.26,"timestamp":1775722091782,"preClose":22.6,"halted":0,"volume":131373,"delay":0,"changeRate":-0.015044247787610612,"floatShares":35929000,"shares":229999999,"eps":1.2397452408930667,"marketStatus":"未开盘","change":-0.34,"latestTime":"04-09 16:08:11","open":22.6,"high":22.62,"low":22.12,"amount":2943708,"amplitude":0.022124,"askPrice":22.32,"askSize":3700,"bidPrice":22.26,"bidSize":100,"shortable":0,"etf":0,"ttmEps":1.2397452408930667,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775784600000},"marketStatusCode":0,"adr":0,"listingDate":1430323200000,"exchange":"SEHK","adjPreClose":22.6,"dividendRate":0.050848,"openAndCloseTimeList":[[1775698200000,1775707200000],[1775710800000,1775721600000]],"volumeRatio":1.044533,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"昊海生科","latestPrice":38.9,"timestamp":1775718000000,"preClose":40.09,"halted":0,"volume":612400,"delay":0,"premium":"-50.15"}},"requestUrl":"/m/hq/s/06826","defaultTab":"news","newsList":[{"id":"1150573291","title":"昊海生物科技2026年3月股份变动月报，购回H股580,700股","url":"https://stock-news.laohu8.com/highlight/detail?id=1150573291","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150573291?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:41","pubTimestamp":1775115679,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年4月2日披露2026年3月股份变动月报。报告期为2026年3月1日至3月31日。截至2026年3月31日，公司注册股本总计229,980,895股，其中A股194,051,855股，H股35,929,040股。本月内，公司通过购回方式减少580,700股H股，同时另行购回的121,800股H股截至月末尚未注销。报告期内未出现新增股份发行、股权激励或可换股票据等其他影响股本的变动。上述月报由联席公司秘书田敏签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622818008","title":"【券商聚焦】中信建投：医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818008","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622818008?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:18","pubTimestamp":1774487918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投表示，医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0287142896.SGD","00241","BK1501","159883","09996","09997","BK1584","BK1100","601066","06826","BK1574","02235","02252","BK1161","BK1589","BK1587","BK1142","BK1583","BK1593","BK1571","01302","00853","BK1222","02190","BK1615","BK1610","BK1591","BK1600","LU0173614495.USD","BK1247","BK0276","BK1502","BK1515","01066","BK1617","BK1585","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127601958","title":"昊海生物科技：3月24日回购14,600股H股，涉资332,344港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127601958","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127601958?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:12","pubTimestamp":1774343529,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年3月24日发布公告，披露当日在香港联交所场内回购14,600股H股，回购价格区间每股22.60港元至23.06港元，合计付出价格332,344港元。本次回购股份数量约占公司当前已发行普通股总数的0.0065%，完成后公司H股发行总数仍为35,929,040股。回购授权于2025年6月10日获得股东大会通过，授权回购股份总数为3,914,184股。截至目前，公司已累计回购2,722,000股，占回购授权通过时公司已发行股本的6.9542%。本次公告由公司董秘兼联席公司秘书田敏签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190911143","title":"昊海生物科技3月23日回购10.72万股，耗资约240.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190911143","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190911143?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:36","pubTimestamp":1774258585,"startTime":"0","endTime":"0","summary":"2026年3月23日，昊海生物科技公布回购股份事项。公司当日在香港联交所场内回购H股共计107,200股，约占公司现有已发行股份总数的0.0474%。本次回购价格介乎每股22.28港元至22.68港元，总涉资约240.55万港元。公告显示，公司已发行股份总数目前为226,132,800股，其中包括190,203,760股A股与35,929,040股H股。此外，公司于2025年6月10日通过的购回授权所允许回购的股份总数为3,914,184股，截至目前已回购2,707,400股。公司确认，此次回购符合法律法规及上市规则的相关规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621501771","title":"昊海生物科技(06826)3月23日耗资约240.55万港元回购10.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621501771","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621501771?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:32","pubTimestamp":1774258365,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布，2026年3月23日耗资约240.55万港元回购10.72万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620737311","title":"昊海生物科技(06826)将派发末期股息每股0.6元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620737311","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620737311?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:51","pubTimestamp":1774018266,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，将派发截至2025年12月31日止年度末期股息每股0.6元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1161","06826","VIG","BK1593","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620673217","title":"昊海生物科技(06826)发布2025年度业绩，股东应占利润2.51亿元，同比下降40.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620673217","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620673217?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:35","pubTimestamp":1774017322,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技 发布截至2025年12月31日止年度业绩，收入24.46亿元，同比下降8.7%;母公司拥有人应占利润2.51亿元，同比下降40.3%;每股基本盈利1.08元，拟派末期股息为每股0.60元(含税)。报告期内，集团经营业绩面临多重外部因素叠加影响。一方面，主要子公司上海其胜受增值税税率从3%调增至13%的影响，导致报告期内相关产品的扣税后销售单价及销售收入均有所下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"昊海生物科技(06826)发布2025年度业绩，股东应占利润2.51亿元，同比下降40.3%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1161","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619454682","title":"昊海生物科技(06826)：眼内用交联透明质酸钠凝胶产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619454682","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619454682?lang=zh_cn&edition=full","pubTime":"2026-03-16 18:36","pubTimestamp":1773657416,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，上海昊海生物科技股份有限公司(以下简称“公司”)全资子公司上海其胜生物制剂有限公司(以下简称“其胜生物”)于近日收到国家药品监督管理局颁发的关于眼内用交联透明质酸钠凝胶产品(以下简称“本产品”)的《中华人民共和国医疗器械注册证》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","159883","BK1100","BK1583","09997","09996","06826","BK1593","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618399355","title":"昊海生物科技拟3月20日举行董事会会议以审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2618399355","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618399355?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:38","pubTimestamp":1773131896,"startTime":"0","endTime":"0","summary":"格隆汇3月10日丨昊海生物科技(06826.HK)公告，谨定于2026年3月20日(星期五)举行董事会会议，藉以(其中包括)审议及通过公司及其附属公司截至2025年12月31日止年度的年度业绩及其发布，以及考虑建议派发末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603101638279546bde4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603101638279546bde4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617665006","title":"昊海生物科技注销58.07万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2617665006","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617665006?lang=zh_cn&edition=full","pubTime":"2026-03-08 10:25","pubTimestamp":1772936700,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　昊海生物科技（06826）发布公告，于2025年12月5日至2025年12月29日期间购回的58.07万股H股股份已于2026年3月6日于香港注销。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-03-08/doc-inhqfsuv1045393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180718474","title":"昊海生物科技（06826）回购约58万股H股，占比约0.2561%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180718474","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180718474?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:51","pubTimestamp":1772790691,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年3月6日披露翌日披露报表，宣布已于2025年12月5日至2025年12月29日期间回购的580,700股H股于2026年3月6日正式注销。该回购股份约占回购前公司已发行H股总数的0.2561%，回购价格为每股26.27港元。注销完成后，H股数量由36,509,740股降至35,929,040股。公司同时披露A股股本未发生变化，A股数量仍为190,203,760股，另有3,848,095股处于库存状态，总股本相应维持在194,051,855股水平。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律程序。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617686027","title":"昊海生物科技(06826)注销58.07万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2617686027","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617686027?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:42","pubTimestamp":1772790164,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2025年12月5日至2025年12月29日期间购回的58.07万股H股股份已于2026年3月6日于香港注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617565632","title":"昊海生物科技03月04日遭主力抛售24.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617565632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617565632?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612142,"startTime":"0","endTime":"0","summary":"03月04日, 昊海生物科技股价跌1.48%，报收24.04元，成交金额174.1万元，换手率0.20%，振幅2.05%，量比0.53。昊海生物科技今日主力资金净流出24.7万元，上一交易日主力净流出84.3万元。该股近5个交易日下跌6.82%，主力资金累计净流入18.5万元；近20日主力资金累计净流入135.9万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161823a6a13d6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161823a6a13d6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128162559","title":"上海昊海生物科技（06826）2月股份变动月报：股本维持230,561,595股，无新增发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1128162559","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128162559?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:22","pubTimestamp":1772526151,"startTime":"0","endTime":"0","summary":"3月3日，上海昊海生物科技股份有限公司公布截至2026年2月28日的股份变动月报。公告显示，公司注册股本为人民币230,561,595元，涵盖36,509,740股H股与194,051,855股A股。报告期内，公司无新增发行股份或股本削减，各类股份数量与上月保持一致。根据公告，公司H股总数与A股总数均未发生变化。截至报告期末，已发行的H股数量为36,509,740股，无库存股；A股则维持在190,203,760股已发行及3,848,095股库存股之合计194,051,855股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332950","title":"昊海生物科技跌超4%去年归母净利同比减少四成至约2.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332950","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616332950?lang=zh_cn&edition=full","pubTime":"2026-03-02 15:31","pubTimestamp":1772436660,"startTime":"0","endTime":"0","summary":"昊海生物科技股价下跌超过4%，报24.54港元，成交额达636.14万港元。根据公司公布的2025年度业绩快报，营业总收入约为24.73亿元，同比减少8.33%；归属于母公司所有者的净利润约为2.51亿元，同比大幅下降40.3%；扣除非经常性损益后的净利润约为1.6亿元，同比减少57.67%。这些因素共同导致了昊海生物科技2025年度业绩表现不佳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302155224a7309226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302155224a7309226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614409831","title":"昊海生物科技(06826)2025年归母净利约2.51亿元，同比减少40.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614409831","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614409831?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:21","pubTimestamp":1772187695,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技 公布2025年度业绩快报，营业总收入约24.73亿元，同比减少8.33%;归属于母公司所有者的净利润约2.51亿元，同比减少40.3%;归属于母公司所有者的扣除非经常性损益的净利润约1.6亿元，同比减少57.67%;基本每股收益1.08元。经初步减值测试，公司对该项无形资产计提减值准备约人民币2498万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151540939","title":"上海昊海生物科技股份有限公司2025年度营收247,301.23万元，经调整净利润16,048.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151540939","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151540939?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:21","pubTimestamp":1772187675,"startTime":"0","endTime":"0","summary":"根据上海昊海生物科技股份有限公司发布的2025年度业绩快报，报告期内实现营收人民币247,301.23万元，同比下降8.33%。经调整后净利润为人民币16,048.17万元，同比下降57.67%。公司管理层指出，人工晶状体产品市场需求和竞争压力加剧，叠加对相关商誉及无形资产计提减值，导致经营利润承压。报告期内，公司对深圳市新产业眼科新技术有限公司相关商誉计提约人民币14,000.00万元减值准备，并对美国子公司Aaren Scientific Inc.所持有的品牌无形资产计提约人民币2,498.00万元减值准备。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611113732","title":"昊海生物科技股东减持计划引关注，股价短期承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2611113732","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611113732?lang=zh_cn&edition=full","pubTime":"2026-02-14 13:38","pubTimestamp":1771047480,"startTime":"0","endTime":"0","summary":"经济观察网昊海生物科技近期最受关注的事件是股东减持计划。该减持计划可能对短期市场情绪构成压力，但符合股东此前的上市承诺。资金流向显示，2月13日A股主力资金净流出约100万元，反映短期资金面承压。机构观点机构对昊海生物科技长期基本面保持关注。机构普遍关注公司医疗器械出海及高端产品线进展，但短期减持事件可能抑制估值修复。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-02-14/doc-inhmuhwq2239746.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-02-14/doc-inhmuhwq2239746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610551921","title":"昊海生物科技(06826)股东楼国梁拟减持不超过100万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2610551921","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610551921?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:24","pubTimestamp":1770902672,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布，楼国梁先生因自身资金需要，计划自本公告披露之日起 3 个交易日后 3 个月内，通过集中竞价和大宗交易方式合计减持不超过100万股的公司股份，占公司总股本的比例不超过 0.4337%，其中，通过集中竞价方式减持不超过100万股，通过大宗交易方式减持不超过100万股。减持价格将根据二级市场价格确定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610914408","title":"韩国投资者再度扫货中国股票 大举买入大模型龙头MiniMax-WP","url":"https://stock-news.laohu8.com/highlight/detail?id=2610914408","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610914408?lang=zh_cn&edition=full","pubTime":"2026-02-12 14:58","pubTimestamp":1770879513,"startTime":"0","endTime":"0","summary":"南方财经2月12日电，据界面新闻，韩国预托结算院（KSD）旗下SEIbro数据显示，截至2月10日，在港交所市场上，韩国股民年内买入金额排名前十的分别为MiniMax-WP、华夏沪深300ETF、澜起科技、安硕恒生科技ETF、南方东英每日杠杆三星电子、英诺赛科、Premia中国科创50ETF、药明合联、歌礼制药、GlobalX中国半导体ETF。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602123649117334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["MCHI","07233","06826","KWEB","CHAU","FXI","DRAG","02168","HSTECH","CWEB","BK4614","03067","03121","CQQQ","BK4585","HXC","09868","XPEV","ASHS","000300.SH","601881","06881","688366","03188","ASHR","BK4588","01672","CGXYY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3healthcare.com/","stockEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0748},{"period":"3month","weight":-0.1332},{"period":"6month","weight":-0.1491},{"period":"1year","weight":-0.0042},{"period":"ytd","weight":-0.0877}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":-0.008},{"period":"3month","weight":-0.0183},{"period":"6month","weight":-0.0205},{"period":"1year","weight":0.2708},{"period":"ytd","weight":0.0048}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海昊海生物科技股份有限公司是一家主要从事生产及销售生物制品、医用透明质酸及人工晶状体、研发生物工程及药品及提供相关服务的中国公司。眼科业务已覆盖白内障治疗、近视防控与屈光矫正及眼表用药、提供人工晶状体及角膜塑形镜等产品的视光材料。医疗美容与创面护理产品覆盖玻尿酸真皮填充剂、皮肤和黏膜浅层组织补充用透明质酸凝胶等。骨科产品包含骨科关节腔黏弹补充剂等。防黏连及止血产品包括医用几丁糖（防黏连用）、医用透明质酸钠凝胶和胶原蛋白海绵。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.002083},{"month":2,"riseRate":0.363636,"avgChangeRate":0.018828},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.014554},{"month":4,"riseRate":0.818182,"avgChangeRate":0.06354},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.008144},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.008696},{"month":7,"riseRate":0.545455,"avgChangeRate":0.056614},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.023358},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.016752},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.029245},{"month":11,"riseRate":0.545455,"avgChangeRate":-0.009618},{"month":12,"riseRate":0.545455,"avgChangeRate":0.02266}],"exchange":"SEHK","name":"昊海生物科技","nameEN":"HAOHAI BIOTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昊海生物科技(06826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昊海生物科技,06826,昊海生物科技股票,昊海生物科技股票老虎,昊海生物科技股票老虎国际,昊海生物科技行情,昊海生物科技股票行情,昊海生物科技股价,昊海生物科技股市,昊海生物科技股票价格,昊海生物科技股票交易,昊海生物科技股票购买,昊海生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昊海生物科技(06826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}